Pharmacological management of cancer-related pain

Eric E. Prommer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Pain occurs in 50% of patients with cancer at the time of diagnosis, and nearly 80% of patients with advanced stage cancer have moderate to severe pain. Assessment of pain requires the health care professional to measure pain intensity, delineate opioid responsiveness, and clarify the impact of pain on a patient’s psychological, social, spiritual, and existential domains. To this end, the World Health Organization (WHO) has developed a 3-step pain ladder to help the health care professional effectively manage pain, classifying pain intensity according to severity and recommending analgesic agents based on their strength. Methods: Health care professionals should follow the WHO guidelines to manage cancer-related pain in their patients. With regard to opioids, dosing, equianalgesic conversions, the management of adverse events, and the identification of new agents are discussed. Integrating adjuvant analgesics and interventional pain techniques into the management of cancer-related pain is also discussed. Results: The WHO analgesic ladder is an effective tool for managing cancer-related pain. Successful pain management in patients with cancer relies upon the health care professional to pay attention to detail, especially during the introduction of new drugs and in identifying potential adverse events. Health care professionals must assess opioid responsiveness to determine whether adjuvant analgesics should also play a role in a patient’s treatment plan. Conclusion: Adherence to the WHO pain ladder and understanding proper use of interventional pain techniques complement the pharmacological management of cancer-related pain.

Original languageEnglish (US)
Pages (from-to)412-425
Number of pages14
JournalCancer Control
Volume22
Issue number4
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Pharmacology
Pain
Analgesics
Delivery of Health Care
Opioid Analgesics
Cancer Pain
Neoplasms
Pain Measurement
Pain Management
Guidelines
Psychology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Prommer, E. E. (2015). Pharmacological management of cancer-related pain. Cancer Control, 22(4), 412-425.

Pharmacological management of cancer-related pain. / Prommer, Eric E.

In: Cancer Control, Vol. 22, No. 4, 01.10.2015, p. 412-425.

Research output: Contribution to journalArticle

Prommer, EE 2015, 'Pharmacological management of cancer-related pain', Cancer Control, vol. 22, no. 4, pp. 412-425.
Prommer, Eric E. / Pharmacological management of cancer-related pain. In: Cancer Control. 2015 ; Vol. 22, No. 4. pp. 412-425.
@article{b8707763656a4eea85164cd24773d904,
title = "Pharmacological management of cancer-related pain",
abstract = "Background: Pain occurs in 50{\%} of patients with cancer at the time of diagnosis, and nearly 80{\%} of patients with advanced stage cancer have moderate to severe pain. Assessment of pain requires the health care professional to measure pain intensity, delineate opioid responsiveness, and clarify the impact of pain on a patient’s psychological, social, spiritual, and existential domains. To this end, the World Health Organization (WHO) has developed a 3-step pain ladder to help the health care professional effectively manage pain, classifying pain intensity according to severity and recommending analgesic agents based on their strength. Methods: Health care professionals should follow the WHO guidelines to manage cancer-related pain in their patients. With regard to opioids, dosing, equianalgesic conversions, the management of adverse events, and the identification of new agents are discussed. Integrating adjuvant analgesics and interventional pain techniques into the management of cancer-related pain is also discussed. Results: The WHO analgesic ladder is an effective tool for managing cancer-related pain. Successful pain management in patients with cancer relies upon the health care professional to pay attention to detail, especially during the introduction of new drugs and in identifying potential adverse events. Health care professionals must assess opioid responsiveness to determine whether adjuvant analgesics should also play a role in a patient’s treatment plan. Conclusion: Adherence to the WHO pain ladder and understanding proper use of interventional pain techniques complement the pharmacological management of cancer-related pain.",
author = "Prommer, {Eric E.}",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "22",
pages = "412--425",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "4",

}

TY - JOUR

T1 - Pharmacological management of cancer-related pain

AU - Prommer, Eric E.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Pain occurs in 50% of patients with cancer at the time of diagnosis, and nearly 80% of patients with advanced stage cancer have moderate to severe pain. Assessment of pain requires the health care professional to measure pain intensity, delineate opioid responsiveness, and clarify the impact of pain on a patient’s psychological, social, spiritual, and existential domains. To this end, the World Health Organization (WHO) has developed a 3-step pain ladder to help the health care professional effectively manage pain, classifying pain intensity according to severity and recommending analgesic agents based on their strength. Methods: Health care professionals should follow the WHO guidelines to manage cancer-related pain in their patients. With regard to opioids, dosing, equianalgesic conversions, the management of adverse events, and the identification of new agents are discussed. Integrating adjuvant analgesics and interventional pain techniques into the management of cancer-related pain is also discussed. Results: The WHO analgesic ladder is an effective tool for managing cancer-related pain. Successful pain management in patients with cancer relies upon the health care professional to pay attention to detail, especially during the introduction of new drugs and in identifying potential adverse events. Health care professionals must assess opioid responsiveness to determine whether adjuvant analgesics should also play a role in a patient’s treatment plan. Conclusion: Adherence to the WHO pain ladder and understanding proper use of interventional pain techniques complement the pharmacological management of cancer-related pain.

AB - Background: Pain occurs in 50% of patients with cancer at the time of diagnosis, and nearly 80% of patients with advanced stage cancer have moderate to severe pain. Assessment of pain requires the health care professional to measure pain intensity, delineate opioid responsiveness, and clarify the impact of pain on a patient’s psychological, social, spiritual, and existential domains. To this end, the World Health Organization (WHO) has developed a 3-step pain ladder to help the health care professional effectively manage pain, classifying pain intensity according to severity and recommending analgesic agents based on their strength. Methods: Health care professionals should follow the WHO guidelines to manage cancer-related pain in their patients. With regard to opioids, dosing, equianalgesic conversions, the management of adverse events, and the identification of new agents are discussed. Integrating adjuvant analgesics and interventional pain techniques into the management of cancer-related pain is also discussed. Results: The WHO analgesic ladder is an effective tool for managing cancer-related pain. Successful pain management in patients with cancer relies upon the health care professional to pay attention to detail, especially during the introduction of new drugs and in identifying potential adverse events. Health care professionals must assess opioid responsiveness to determine whether adjuvant analgesics should also play a role in a patient’s treatment plan. Conclusion: Adherence to the WHO pain ladder and understanding proper use of interventional pain techniques complement the pharmacological management of cancer-related pain.

UR - http://www.scopus.com/inward/record.url?scp=84951843020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951843020&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84951843020

VL - 22

SP - 412

EP - 425

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 4

ER -